Lv1
80 积分 2022-04-12 加入
Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma
22天前
已完结
Bioorthogonal chemistry for prodrug activation in vivo
24天前
已完结
Challenging and new opportunities for prodrug technology
24天前
已完结
The present and future of bispecific antibodies for cancer therapy
26天前
已完结
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
26天前
已完结
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Detection and Characterization of In Vitro Payload-Containing Catabolites of Noncleavable Antibody-Drug Conjugates by High-Resolution Mass Spectrometry and Multiple Data Mining Tools
1个月前
已完结
Phase I results for AMG 133
2个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2个月前
已完结
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders
Relationship between Effective Refractory Period and Inducibility of Atrial Fibrillation from the Superior Vena Cava after Pulmonary Vein Isolation
皖公网安备34019202002308
